- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.09 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NAP.3: 24 residues within 4Å:- Chain A: Y.25, G.26, S.27, Q.28, I.47, R.48, S.52, L.79, L.80, P.81, D.82, I.84, Q.85, A.106, H.107, P.129, G.131, P.132, G.133
- Chain B: S.249, I.250, S.251
- Ligands: EKD.4, EKA.7
25 PLIP interactions:23 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:Q.28
- Hydrogen bonds: A:Y.25, A:Y.25, A:S.27, A:S.27, A:Q.28, A:Q.28, A:R.48, A:S.52, A:S.52, A:L.80, A:D.82, A:Q.85, A:G.133, B:S.249
- Water bridges: A:G.26, A:S.27, A:S.27, A:G.29, A:R.51, A:R.51, A:H.107, B:S.251
- Salt bridges: A:R.48
- pi-Cation interactions: A:R.48
NAP.9: 26 residues within 4Å:- Chain A: S.249, I.250, S.251
- Chain B: G.24, Y.25, G.26, S.27, Q.28, I.47, R.48, S.52, V.66, L.79, L.80, P.81, D.82, I.84, Q.85, V.88, A.106, H.107, P.129, G.131, P.132, G.133
- Ligands: EKD.6
28 PLIP interactions:5 interactions with chain A, 23 interactions with chain B- Hydrogen bonds: A:S.249, A:S.251, B:Y.25, B:Y.25, B:S.27, B:S.27, B:S.27, B:Q.28, B:Q.28, B:R.48, B:R.48, B:S.52, B:S.52, B:L.80, B:D.82, B:Q.85, B:G.133
- Water bridges: A:N.252, A:N.252, A:N.252, B:G.26, B:G.29, B:P.49, B:F.53, B:H.107
- Hydrophobic interactions: B:Q.28
- Salt bridges: B:R.48
- pi-Cation interactions: B:R.48
- 2 x EKD: (cyclohexylamino)(oxo)acetic acid(Non-covalent)
EKD.4: 14 residues within 4Å:- Chain A: P.132, D.190, E.194, L.198, C.199
- Chain B: E.230, I.234, I.250, S.251, A.254
- Ligands: MG.1, MG.2, NAP.3, EKA.7
9 PLIP interactions:6 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:E.230, B:I.234, B:I.250, A:L.198
- Hydrogen bonds: B:E.230, B:S.251, A:E.194
- Water bridges: B:S.251, A:K.130
EKD.6: 10 residues within 4Å:- Chain A: I.250, S.251, A.254
- Chain B: G.131, P.132, D.190, E.194
- Ligands: MG.5, MG.8, NAP.9
8 PLIP interactions:4 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:P.132
- Water bridges: B:K.130, B:K.130, B:E.194, A:E.226, A:S.251, A:S.251
- Hydrogen bonds: A:S.251
- 1 x EKA: [cyclohexyl(hydroxy)amino](oxo)acetic acid(Non-covalent)
EKA.7: 14 residues within 4Å:- Chain A: P.132, D.190, E.194, L.198, C.199
- Chain B: E.230, I.234, I.250, S.251, A.254
- Ligands: MG.1, MG.2, NAP.3, EKD.4
14 PLIP interactions:6 interactions with chain B, 8 interactions with chain A- Hydrophobic interactions: B:E.230, B:I.234, B:I.250, A:P.132, A:L.198, A:L.198
- Hydrogen bonds: B:S.251
- Water bridges: B:E.226, B:S.251, A:P.129, A:K.130, A:K.130, A:D.190, A:E.194
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kandale, A. et al., Design, synthesis, in vitro activity and crystallisation of novel N-isopropyl-N-hydroxyoxamate derivatives as ketol-acid reductoisomerase (KARI) inhibitors. To Be Published
- Release Date
- 2019-01-16
- Peptides
- Ketol-acid reductoisomerase (NADP(+)): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.09 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x EKD: (cyclohexylamino)(oxo)acetic acid(Non-covalent)
- 1 x EKA: [cyclohexyl(hydroxy)amino](oxo)acetic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kandale, A. et al., Design, synthesis, in vitro activity and crystallisation of novel N-isopropyl-N-hydroxyoxamate derivatives as ketol-acid reductoisomerase (KARI) inhibitors. To Be Published
- Release Date
- 2019-01-16
- Peptides
- Ketol-acid reductoisomerase (NADP(+)): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B